Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

497
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
497
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

582
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
582

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes.

Science advances·2024
Same author

Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina.

Gene therapy·2021
Same author

Suprachoroidal gene transfer with nonviral nanoparticles.

Science advances·2020
Same author

Gelling hypotonic polymer solution for extended topical drug delivery to the eye.

Nature biomedical engineering·2020
Same author

Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles.

Nature communications·2020
Same author

Metipranolol promotes structure and function of retinal photoreceptors in the rd10 mouse model of human retinitis pigmentosa.

Journal of neurochemistry·2018
Same journal

Spaceflight-associated neuro-ocular syndrome (SANS): expert consensus on diagnosis and management.

Eye (London, England)·2026
Same journal

Development of a deep learning model to predict cycloplegic myopia and pre- myopia: based on a large-scale screening of school-aged children.

Eye (London, England)·2026
Same journal

Comparative analysis of quantitative fundus results of the left and right eyes and screening for coronary atherosclerotic disease: a binocular study.

Eye (London, England)·2026
Same journal

Retinal ischemic perivascular lesions in cortical cerebral infarction: a comparison against controls.

Eye (London, England)·2026
Same journal

Exploring variations in Certificate of Vision Impairment (CVI) with geographical locations, deprivation indices, density of optometry practices and number of older people living in Mid and South Essex: an analysis of publicly available data.

Eye (London, England)·2026
Same journal

Functional visual loss: a systematic review and meta-analysis of epidemiology, prognosis and treatment.

Eye (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 27, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.2K

Peripheral photocoagulation not the answer for DMO

Peter A Campochiaro1

  • 1The Wilmer Eye Institute, Departments of Ophthalmology and Neuroscience, The Johns Hopkins University School of Medicine, Baltimore, MD, USA. pcampo@jhmi.edu.

Eye (London, England)
|June 5, 2023
PubMed
Summary

No abstract available in PubMed .

More Related Videos

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.9K
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.2K

Related Experiment Videos

Last Updated: Jul 27, 2025

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
10:24

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

10.2K
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

7.9K
Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.2K